# Zoledronic Acid

## Aclasta inj 5mg/100mL

| TAH Drug Code      | [IACL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IACL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment and prevention of postmenopausal osteoporosis. Treatment to increase bone mass in men with osteoporosis. Treatment and prevention of glucocorticoid-induced osteoporosis. Treatment of Pagetâ€™s disease of bone in men and women.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | IVDï¼Œ 5 mg once every year.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Hypocalcemia. Patients with creatinine clearance less than 35 mL/min and in those with evidence of acute renal impairment. Hypersensitivity to any component of Aclasta.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Common: Peripheral edema (Paget diseaseï¼Œ 3%; osteoporosisï¼Œ 4.6-5.5%; osteopeniaï¼Œ 3.9-5.6%; hypercalcemia of malignancyï¼Œ 5-<10%; bone metastasisï¼Œ 21%)ï¼Œ Weight decreased (bone metastasisï¼Œ 16%)ï¼Œ Abdominal pain (osteoporosis (female)ï¼Œ 0.9-4.6%; osteoporosis (male)ï¼Œ 7.9%; osteoporosis (male and female)ï¼Œ 7.5%; osteopeniaï¼Œ 6.6-8.6%; Paget diseaseï¼Œ 2%; hypercalcemia of malignancyï¼Œ 16%; bone metastasisï¼Œ 14%)ï¼Œ Constipation (Paget diseaseï¼Œ 6%; hypercalcemia of malignancyï¼Œ 27%)ï¼Œ Diarrhea (osteoporosisï¼Œ 5.2-6%; osteopeniaï¼Œ 6.6-8.1%; Paget diseaseï¼Œ 6%; hypercalcemia of malignancyï¼Œ 17%; bone metastasisï¼Œ 24%)ï¼Œ Loss of appetite (osteoporosisï¼Œ 1-2%; osteopeniaï¼Œ 0.6-2%; Paget diseaseï¼Œ 2%; hypercalcemia of malignancyï¼Œ 9%; bone metastasisï¼Œ 22%)ï¼Œ Nausea (osteoporosis (female)ï¼Œ 4.5-8.5%; osteoporosis (male and female)ï¼Œ 9.6%; osteopeniaï¼Œ 11.6-17.7%; Paget diseaseï¼Œ 9%; hypercalcemia of malignancyï¼Œ 29%; bone metastasisï¼Œ 46%)ï¼Œ Vomiting (Paget diseaseï¼Œ 2%; osteoporosisï¼Œ 3.4-4.6%; osteopeniaï¼Œ 5-7.6%; hypercalcemia of malignancyï¼Œ 14%; bone metastasisï¼Œ 32%)ï¼Œ Arthralgia (Osteoporosis (female)ï¼Œ 17.9-23.8%ï¼Œ (acute phaseï¼Œ 3-7%); osteoporosis (maleï¼Œ acute phase)ï¼Œ 11.1%; osteopeniaï¼Œ 18.8-27.3%ï¼Œ (acute phaseï¼Œ 6.1%); hypercalcemia of malignancyï¼Œ 5-<10%; Paget diseaseï¼Œ 9%; bone metastasisï¼Œ 21%)ï¼Œ Backache (Osteoporosis (male and female)ï¼Œ 4.3%; osteoporosis (maleï¼Œ acute phase)ï¼Œ 3.3%; osteopeniaï¼Œ 16.6-18.2%ï¼Œ (acute phaseï¼Œ 1.7%); Paget diseaseï¼Œ 4%; bone metastasisï¼Œ 15%)ï¼Œ Pain in limb (Osteoporosis (female)ï¼Œ 5.9-11.3%; osteoporosis (male and female)ï¼Œ 3.1%; osteopeniaï¼Œ 11.1-16%ï¼Œ (acute phaseï¼Œ 3.9%); bone metastasisï¼Œ 14%)ï¼Œ Asthenia (osteoporosisï¼Œ 3.2 to 5.3%; osteopeniaï¼Œ 2.8-6.1%; Paget diseaseï¼Œ 2%; hypercalcemia of malignancyï¼Œ 5-<10%; bone metastasisï¼Œ 24%)ï¼Œ Dizziness (osteoporosisï¼Œ 2-7.6%; osteopeniaï¼Œ 6.1-7.6%; Paget diseaseï¼Œ 9%; bone metastasisï¼Œ 18%)ï¼Œ Headache (osteoporosis (female)ï¼Œ 3.9-12.4%ï¼Œ (acute phaseï¼Œ 7%); osteoporosis (male)ï¼Œ 15%ï¼Œ (acute phaseï¼Œ 9.8%); osteopeniaï¼Œ 14.6-20.4%ï¼Œ (acute phaseï¼Œ 13.3%); Paget diseaseï¼Œ 11%; hypercalcemia of malignancyï¼Œ 5-<10%; bone metastasisï¼Œ 19%)ï¼Œ Insomnia (hypercalcemia of malignancyï¼Œ 15%; bone metastasisï¼Œ 16%)ï¼Œ Paresthesia (Paget diseaseï¼Œ 2%; bone metastasisï¼Œ 15% .)ï¼Œ Nephrotoxicity (bone metastasisï¼Œ 11-17%)ï¼Œ Fatigue (osteoporosis (female)ï¼Œ 2.1-5.4%; osteoporosis (male)ï¼Œ 17.6%ï¼Œ (acute phaseï¼Œ 12.4%); osteopeniaï¼Œ 9.9-14.6%ï¼Œ (acute phaseï¼Œ 8.3%); Paget diseaseï¼Œ 8%; bone metastasisï¼Œ 39%)ï¼Œ Fever (osteoporosis (femaleï¼Œ acute phase)ï¼Œ 7-18%; osteoporosis (maleï¼Œ acute phase)ï¼Œ 15.7%; osteopeniaï¼Œ 21-21.7% (acute phaseï¼Œ 19.3%); Paget diseaseï¼Œ 3-11%; hypercalcemia of malignancy (acute phase)ï¼Œ 44%; bone metastasisï¼Œ 32%) Serious: Atrial fibrillation (osteoporosis (female)ï¼Œ 1.3-2.8%; osteoporosis (male)ï¼Œ 3.3%; osteoporosis (male and female)ï¼Œ 0.7%)ï¼Œ Cardiac dysrhythmiaï¼Œ Stevens-Johnson syndromeï¼Œ Toxic epidermal necrolysisï¼Œ Hypocalcemia (Osteoporosisï¼Œ up to 0.2%; hypercalcemia of malignancyï¼Œ 5-<10%; bone metastasisï¼Œ 1.3%; Paget diseaseï¼Œ 3-21%)ï¼Œ Bone pain (Osteoporosis (female)ï¼Œ 3.2-5.8%; osteoporosis (male and female)ï¼Œ 3.1%; osteopeniaï¼Œ 3.3-5.1%; Paget diseaseï¼Œ 9%; hypercalcemia of malignancyï¼Œ 12%; bone metastasisï¼Œ 55%)ï¼Œ Myalgia (Osteoporosis (female)ï¼Œ 4.9-11.7%ï¼Œ (acute phaseï¼Œ 9%); osteoporosis (male)ï¼Œ 19.6%ï¼Œ (acute phaseï¼Œ 17.1%); osteopeniaï¼Œ 19.2-22.7%; Paget diseaseï¼Œ 7%; bone metastasisï¼Œ 23%)ï¼Œ Necrosis of boneï¼Œ acuteï¼Œ Osteonecrosis of jawï¼Œ Tetanyï¼Œ Cerebrovascular accident (osteoporosisï¼Œ 2.3%)ï¼Œ Numbnessï¼Œ Seizureï¼Œ Nephrotoxic acute renal failureï¼Œ Serum creatinine above reference range (osteoporosisï¼Œ 1.2-2.1%; bone metastasisï¼Œ 1%; hypercalcemia of malignancyï¼Œ 2%)ï¼Œ Dyspnea (Paget diseaseï¼Œ 5%; osteoporosis (male)ï¼Œ 6.5%; hypercalcemia of malignancyï¼Œ 22%; bone metastasisï¼Œ 27%) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/zoledronic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

## Bolenic IV infusion 4mg

| TAH Drug Code      | [IBOL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IBOL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of skeletal related events (pathological fracturesï¼Œ spinal compressionï¼Œ radiation or surgery to boneï¼Œ or tumor-induced hypercalcemia) in patients with advanced malignancies involving bone. Treatment of hypercalcemia of malignancy (HCM).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | IVDï¼Œ 4 mg once every 3-4 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | The zoledronic acid powder used to prepare the infusion solution should not be used in pregnant womenï¼Œ breastfeeding womenï¼Œ or in patients who have clinically significant allergic reactions to zoledronic acidï¼Œ other bisphosphonatesï¼Œ or any excipients in the formulation of zoledronic acid. Zoledronic acid injection should not be used in pregnant or breastfeeding women.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Common: Peripheral edema (Paget diseaseï¼Œ 3%; osteoporosisï¼Œ 4.6-5.5%; osteopeniaï¼Œ 3.9-5.6%; hypercalcemia of malignancyï¼Œ 5-<10%; bone metastasisï¼Œ 21%)ï¼Œ Weight decreased (bone metastasisï¼Œ 16%)ï¼Œ Abdominal pain (osteoporosis (female)ï¼Œ 0.9-4.6%; osteoporosis (male)ï¼Œ 7.9%; osteoporosis (male and female)ï¼Œ 7.5%; osteopeniaï¼Œ 6.6-8.6%; Paget diseaseï¼Œ 2%; hypercalcemia of malignancyï¼Œ 16%; bone metastasisï¼Œ 14%)ï¼Œ Constipation (Paget diseaseï¼Œ 6%; hypercalcemia of malignancyï¼Œ 27%)ï¼Œ Diarrhea (osteoporosisï¼Œ 5.2-6%; osteopeniaï¼Œ 6.6-8.1%; Paget diseaseï¼Œ 6%; hypercalcemia of malignancyï¼Œ 17%; bone metastasisï¼Œ 24%)ï¼Œ Loss of appetite (osteoporosisï¼Œ 1-2%; osteopeniaï¼Œ 0.6-2%; Paget diseaseï¼Œ 2%; hypercalcemia of malignancyï¼Œ 9%; bone metastasisï¼Œ 22%)ï¼Œ Nausea (osteoporosis (female)ï¼Œ 4.5-8.5%; osteoporosis (male and female)ï¼Œ 9.6%; osteopeniaï¼Œ 11.6-17.7%; Paget diseaseï¼Œ 9%; hypercalcemia of malignancyï¼Œ 29%; bone metastasisï¼Œ 46%)ï¼Œ Vomiting (Paget diseaseï¼Œ 2%; osteoporosisï¼Œ 3.4-4.6%; osteopeniaï¼Œ 5-7.6%; hypercalcemia of malignancyï¼Œ 14%; bone metastasisï¼Œ 32%)ï¼Œ Arthralgia (Osteoporosis (female)ï¼Œ 17.9-23.8%ï¼Œ (acute phaseï¼Œ 3-7%); osteoporosis (maleï¼Œ acute phase)ï¼Œ 11.1%; osteopeniaï¼Œ 18.8-27.3%ï¼Œ (acute phaseï¼Œ 6.1%); hypercalcemia of malignancyï¼Œ 5-<10%; Paget diseaseï¼Œ 9%; bone metastasisï¼Œ 21%)ï¼Œ Backache (Osteoporosis (male and female)ï¼Œ 4.3%; osteoporosis (maleï¼Œ acute phase)ï¼Œ 3.3%; osteopeniaï¼Œ 16.6-18.2%ï¼Œ (acute phaseï¼Œ 1.7%); Paget diseaseï¼Œ 4%; bone metastasisï¼Œ 15%)ï¼Œ Pain in limb (Osteoporosis (female)ï¼Œ 5.9-11.3%; osteoporosis (male and female)ï¼Œ 3.1%; osteopeniaï¼Œ 11.1-16%ï¼Œ (acute phaseï¼Œ 3.9%); bone metastasisï¼Œ 14%)ï¼Œ Asthenia (osteoporosisï¼Œ 3.2 to 5.3%; osteopeniaï¼Œ 2.8-6.1%; Paget diseaseï¼Œ 2%; hypercalcemia of malignancyï¼Œ 5-<10%; bone metastasisï¼Œ 24%)ï¼Œ Dizziness (osteoporosisï¼Œ 2-7.6%; osteopeniaï¼Œ 6.1-7.6%; Paget diseaseï¼Œ 9%; bone metastasisï¼Œ 18%)ï¼Œ Headache (osteoporosis (female)ï¼Œ 3.9-12.4%ï¼Œ (acute phaseï¼Œ 7%); osteoporosis (male)ï¼Œ 15%ï¼Œ (acute phaseï¼Œ 9.8%); osteopeniaï¼Œ 14.6-20.4%ï¼Œ (acute phaseï¼Œ 13.3%); Paget diseaseï¼Œ 11%; hypercalcemia of malignancyï¼Œ 5-<10%; bone metastasisï¼Œ 19%)ï¼Œ Insomnia (hypercalcemia of malignancyï¼Œ 15%; bone metastasisï¼Œ 16%)ï¼Œ Paresthesia (Paget diseaseï¼Œ 2%; bone metastasisï¼Œ 15% .)ï¼Œ Nephrotoxicity (bone metastasisï¼Œ 11-17%)ï¼Œ Fatigue (osteoporosis (female)ï¼Œ 2.1-5.4%; osteoporosis (male)ï¼Œ 17.6%ï¼Œ (acute phaseï¼Œ 12.4%); osteopeniaï¼Œ 9.9-14.6%ï¼Œ (acute phaseï¼Œ 8.3%); Paget diseaseï¼Œ 8%; bone metastasisï¼Œ 39%)ï¼Œ Fever (osteoporosis (femaleï¼Œ acute phase)ï¼Œ 7-18%; osteoporosis (maleï¼Œ acute phase)ï¼Œ 15.7%; osteopeniaï¼Œ 21-21.7% (acute phaseï¼Œ 19.3%); Paget diseaseï¼Œ 3-11%; hypercalcemia of malignancy (acute phase)ï¼Œ 44%; bone metastasisï¼Œ 32%) Serious: Atrial fibrillation (osteoporosis (female)ï¼Œ 1.3-2.8%; osteoporosis (male)ï¼Œ 3.3%; osteoporosis (male and female)ï¼Œ 0.7%)ï¼Œ Cardiac dysrhythmiaï¼Œ Stevens-Johnson syndromeï¼Œ Toxic epidermal necrolysisï¼Œ Hypocalcemia (Osteoporosisï¼Œ up to 0.2%; hypercalcemia of malignancyï¼Œ 5-<10%; bone metastasisï¼Œ 1.3%; Paget diseaseï¼Œ 3-21%)ï¼Œ Bone pain (Osteoporosis (female)ï¼Œ 3.2-5.8%; osteoporosis (male and female)ï¼Œ 3.1%; osteopeniaï¼Œ 3.3-5.1%; Paget diseaseï¼Œ 9%; hypercalcemia of malignancyï¼Œ 12%; bone metastasisï¼Œ 55%)ï¼Œ Myalgia (Osteoporosis (female)ï¼Œ 4.9-11.7%ï¼Œ (acute phaseï¼Œ 9%); osteoporosis (male)ï¼Œ 19.6%ï¼Œ (acute phaseï¼Œ 17.1%); osteopeniaï¼Œ 19.2-22.7%; Paget diseaseï¼Œ 7%; bone metastasisï¼Œ 23%)ï¼Œ Necrosis of boneï¼Œ acuteï¼Œ Osteonecrosis of jawï¼Œ Tetanyï¼Œ Cerebrovascular accident (osteoporosisï¼Œ 2.3%)ï¼Œ Numbnessï¼Œ Seizureï¼Œ Nephrotoxic acute renal failureï¼Œ Serum creatinine above reference range (osteoporosisï¼Œ 1.2-2.1%; bone metastasisï¼Œ 1%; hypercalcemia of malignancyï¼Œ 2%)ï¼Œ Dyspnea (Paget diseaseï¼Œ 5%; osteoporosis (male)ï¼Œ 6.5%; hypercalcemia of malignancyï¼Œ 22%; bone metastasisï¼Œ 27%) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/zoledronic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

